These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 34955621)

  • 21. Understanding the Driving Forces That Trigger Mutations in SARS-CoV-2: Mutational Energetics and the Role of Arginine Blockers in COVID-19 Therapy.
    Ridgway H; Chasapis CT; Kelaidonis K; Ligielli I; Moore GJ; Gadanec LK; Zulli A; Apostolopoulos V; Mavromoustakos T; Matsoukas JM
    Viruses; 2022 May; 14(5):. PubMed ID: 35632769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential inhibitor for blocking binding between ACE2 and SARS-CoV-2 spike protein with mutations.
    Tsai MS; Shih WT; Yang YH; Lin YS; Chang GH; Hsu CM; Yeh RA; Shu LH; Cheng YC; Liu HT; Wu YH; Wu YH; Shen RC; Wu CY
    Biomed Pharmacother; 2022 May; 149():112802. PubMed ID: 35279013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased Interfacial Dynamics Caused by the N501Y Mutation in the SARS-CoV-2 S1 Spike:ACE2 Complex.
    Ahmed WS; Philip AM; Biswas KH
    Front Mol Biosci; 2022; 9():846996. PubMed ID: 35936792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural and simulation analysis of hotspot residues interactions of SARS-CoV 2 with human ACE2 receptor.
    Veeramachaneni GK; Thunuguntla VBSC; Bobbillapati J; Bondili JS
    J Biomol Struct Dyn; 2021 Jul; 39(11):4015-4025. PubMed ID: 32448098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential Interactions Between Human ACE2 and Spike RBD of SARS-CoV-2 Variants of Concern.
    Kim S; Liu Y; Lei Z; Dicker J; Cao Y; Zhang XF; Im W
    bioRxiv; 2021 Jul; ():. PubMed ID: 34341794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamics of the ACE2-SARS-CoV-2/SARS-CoV spike protein interface reveal unique mechanisms.
    Ali A; Vijayan R
    Sci Rep; 2020 Aug; 10(1):14214. PubMed ID: 32848162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Leading Compounds from
    Islam MN; Pramanik MEA; Hossain MA; Rahman MH; Hossen MS; Islam MA; Miah MMZ; Ahmed I; Hossain AM; Haque MJ; Islam AM; Ali MN; Jahan RA; Haque ME; Rahman MM; Hasan MS; Rahman MM; Kabir MM; Basak PM; Sarkar MAM; Islam MS; Rahman MR; Prodhan AA; Mosaddik A; Haque H; Fahmin F; Das HS; Islam MM; Emtia C; Gofur MR; Liang A; Akbar SMF
    Euroasian J Hepatogastroenterol; 2023; 13(2):89-107. PubMed ID: 38222948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening of inhibitors against SARS-CoV-2 spike protein and their capability to block the viral entry mechanism: A viroinformatics study.
    Farouk AE; Baig MH; Khan MI; Park T; Alotaibi SS; Dong JJ
    Saudi J Biol Sci; 2021 Jun; 28(6):3262-3269. PubMed ID: 33654454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro data suggest that Indian delta variant B.1.617 of SARS-CoV-2 escapes neutralization by both receptor affinity and immune evasion.
    Augusto G; Mohsen MO; Zinkhan S; Liu X; Vogel M; Bachmann MF
    Allergy; 2022 Jan; 77(1):111-117. PubMed ID: 34453338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GB-2 blocking the interaction between ACE2 and wild type and mutation of spike protein of SARS-CoV-2.
    Tsai MS; Yang YH; Lin YS; Chang GH; Hsu CM; Yeh RA; Shu LH; Cheng YC; Liu HT; Wu YH; Wu YH; Shen RC; Wu CY
    Biomed Pharmacother; 2021 Oct; 142():112011. PubMed ID: 34388530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insilico study on the effect of SARS-CoV-2 RBD hotspot mutants' interaction with ACE2 to understand the binding affinity and stability.
    Verma J; Subbarao N
    Virology; 2021 Sep; 561():107-116. PubMed ID: 34217923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Receptor binding domain of SARS-CoV-2 from Wuhan strain to Omicron B.1.1.529 attributes increased affinity to variable structures of human ACE2.
    Patil S; Alzahrani KJ; Banjer HJ; Halawani IF; Alzahrani H; Altayar MA; Albogami S; Angeles RF; Hassan AAA; Bhandi S; Raj AT
    J Infect Public Health; 2022 Jul; 15(7):781-787. PubMed ID: 35738053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Omicron (BA.1) and sub-variants (BA.1.1, BA.2, and BA.3) of SARS-CoV-2 spike infectivity and pathogenicity: A comparative sequence and structural-based computational assessment.
    Kumar S; Karuppanan K; Subramaniam G
    J Med Virol; 2022 Oct; 94(10):4780-4791. PubMed ID: 35680610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uncovering the impact of SARS-CoV2 spike protein variants on human receptors: A molecular dynamics docking and simulation approach.
    Zaheer M; Ali N; Javed H; Munir R; Jamil N
    J Infect Public Health; 2023 Oct; 16(10):1544-1555. PubMed ID: 37566991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atomistic insights into the binding of SARS-CoV-2 spike receptor binding domain with the human ACE2 receptor: The importance of residue 493.
    Carter C; Airas J; Parish CA
    J Mol Graph Model; 2023 Jan; 118():108360. PubMed ID: 36401897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity.
    Chakraborty S
    Biochem Biophys Res Commun; 2021 Jan; 534():374-380. PubMed ID: 33272568
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Pandey AK; Verma S
    Drug Dev Ind Pharm; 2022 Oct; 48(10):539-551. PubMed ID: 36250723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular Epidemiology of SARS-CoV-2: The Dominant Role of Arginine in Mutations and Infectivity.
    Ridgway H; Ntallis C; Chasapis CT; Kelaidonis K; Matsoukas MT; Plotas P; Apostolopoulos V; Moore G; Tsiodras S; Paraskevis D; Mavromoustakos T; Matsoukas JM
    Viruses; 2023 Jan; 15(2):. PubMed ID: 36851526
    [No Abstract]   [Full Text] [Related]  

  • 39. Adsorption of SARS-CoV-2 Spike (N501Y) RBD to Human Angiotensin-Converting Enzyme 2 at a Lipid/Water Interface.
    Rozak H; Nihonyanagi S; Myalitsin A; Roy S; Ahmed M; Tahara T; Rzeznicka II
    J Phys Chem B; 2023 May; 127(20):4406-4414. PubMed ID: 37171105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative Structural Analysis of Human ACE2 Receptor with Spike Protein of SARS-CoV-2 Variants: Implications to Understand Infectivity of the Virus.
    Koley T; Goswami A; Kumar M; Upadhyay N; Hariprasad G
    Adv Appl Bioinform Chem; 2022; 15():21-27. PubMed ID: 35734581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.